Tevogen Bio Holdings Inc. Quarterly Costs and Expenses in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Tevogen Bio Holdings Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2021 to Q1 2024.
  • Tevogen Bio Holdings Inc. Costs and Expenses for the quarter ending March 31, 2024 was $29.5M, a 1170% increase year-over-year.
  • Tevogen Bio Holdings Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $29.5M, a 884% increase year-over-year.
  • Tevogen Bio Holdings Inc. annual Costs and Expenses for 2023 was $2.27M, a 139% increase from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $29.5M $29.5M +$27.2M +1170% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-28
Q4 2023 $2.27M -$1.18M -$1.4M -656% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-29
Q3 2023 $3.67M $606K +$407K +205% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.26M $527K +$268K +104% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $2.99M $2.32M +$2.04M +722% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-28
Q4 2022 $953K $213K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-29
Q3 2022 $199K +$199K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $259K +$247K +2189% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $283K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q3 2021 $115* Jul 1, 2021 Sep 30, 2021 10-Q 2021-12-17
Q2 2021 $11.3K Apr 21, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.